India’s Lupin Expands its Presence In Japan with I’rom Pharmaceutical Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 12 (Table of Contents)
Published: 5 Dec-2011
DOI: 10.3833/pdr.v2011.i12.1621 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Following its acquisition of Kyowa Pharmaceutical Industry in 2007, the Indian generics company Lupin has made its second foray into the Japanese generics market by agreeing to acquire up to 100% of the outstanding shares of I’rom Pharmaceutical, a manufacturer of generic injectables...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS